Butler J, Yang M, Manzi MA et al (2019) Clinical course of patients with worsening heart failure with reduced ejection fraction. J Am Coll Cardiol 73:935–944. https://doi.org/10.1016/j.jacc.2018.11.049
Savarese G, Becher PM, Lund LH et al (2023) Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res 118:3272–3287. https://doi.org/10.1093/cvr/cvac013
Article CAS PubMed Google Scholar
James SL, Abate D, Abate KH et al (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392:1789–1858. https://doi.org/10.1016/S0140-6736(18)32279-7
Bozkurt B, Ahmad T, Alexander KM et al (2023) Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America. J Card Fail 29:1412–1451. https://doi.org/10.1016/j.cardfail.2023.07.006
Article PubMed Central PubMed Google Scholar
Groenewegen A, Rutten FH, Mosterd A, Hoes AW (2020) Epidemiology of heart failure. Eur J Heart Fail 22:1342–1356. https://doi.org/10.1002/ejhf.1858
Ceia F, Fonseca C, Mota T et al (2002) Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail 4:531–539. https://doi.org/10.1016/S1388-9842(02)00034-X
Fonseca C, Brás D, Araújo I, Ceia F (2018) Insuficiência cardíaca em números: estimativas para o século XXI em Portugal. Rev Port Cardiol 37:97–104. https://doi.org/10.1016/j.repc.2017.11.010
Baptista R et al (2024) PORTHOS - Portuguese Heart Failure Prevalence Observational Study. In: Heart Failure 2024. p Saturday, 11 May-Tuesday, 14 May 2024 Lisbon-P
Baptista R, Silva Cardoso J, Canhão H et al (2023) Portuguese Heart Failure Prevalence Observational Study (PORTHOS) rationale and design – A population-based study. Rev Port Cardiol 42:985–995. https://doi.org/10.1016/j.repc.2023.10.004
Gouveia MR de A, Ascenção RMS e S, Fiorentino F, et al (2020) Os custos da insuficiência cardíaca em Portugal e a sua evolução previsível com o envelhecimento da população. Rev Port Cardiol 39:3–11. https://doi.org/10.1016/j.repc.2019.09.006
Gouveia M, Ascenção R, Fiorentino F et al (2019) The current and future burden of heart failure in Portugal. ESC Hear Fail 6:254–261. https://doi.org/10.1002/ehf2.12399
Clark H, Rana R, Gow J et al (2022) Hospitalisation costs associated with heart failure with preserved ejection fraction (HFpEF): a systematic review. Heart Fail Rev 27:559–572. https://doi.org/10.1007/s10741-021-10097-7
Hessel FP (2021) Overview of the socio-economic consequences of heart failure. Cardiovasc Diagn Ther 11:254–262. https://doi.org/10.21037/cdt-20-291
Article PubMed Central PubMed Google Scholar
Osenenko KM, Kuti E, Deighton AM et al (2022) Burden of hospitalization for heart failure in the United States: a systematic literature review. J Manag Care Spec Pharm 28:157–167. https://doi.org/10.18553/jmcp.2022.28.2.157
Johansson I, Joseph P, Balasubramanian K et al (2021) Health-related quality of life and mortality in heart failure: the global congestive heart failure study of 23 000 patients from 40 countries. Circulation 143:2129–2142. https://doi.org/10.1161/CIRCULATIONAHA.120.050850
Article CAS PubMed Google Scholar
Freedland KE, Rich MW, Carney RM (2021) Improving quality of life in heart failure. Curr Cardiol Rep 23:159. https://doi.org/10.1007/s11886-021-01588-y
Mulugeta H, Sinclair PM, Wilson A (2023) Prevalence of depression and its association with health-related quality of life in people with heart failure in low- and middle-income countries: a systematic review and meta-analysis. PLoS ONE 18:e0283146. https://doi.org/10.1371/journal.pone.0283146
Article CAS PubMed Central PubMed Google Scholar
Taylor CJ, Ordóñez-Mena JM, Jones NR et al (2021) National trends in heart failure mortality in men and women, United Kingdom, 2000–2017. Eur J Heart Fail 23:3–12. https://doi.org/10.1002/ejhf.1996
Koh AS, Tay WT, Teng THK et al (2017) A comprehensive population-based characterization of heart failure with mid-range ejection fraction. Eur J Heart Fail 19:1624–1634. https://doi.org/10.1002/ejhf.945
Chen S, Huang Z, Liang Y et al (2022) Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort. ESC Hear Fail 9:2336–2347. https://doi.org/10.1002/ehf2.13921
Shah KS, Xu H, Matsouaka RA et al (2017) Heart failure with preserved, borderline, and reduced ejection fraction. J Am Coll Cardiol 70:2476–2486. https://doi.org/10.1016/j.jacc.2017.08.074
Nagata T, Ide T, Tohyama T et al (2023) Long-term outcomes of heart failure patients with preserved, mildly reduced, and reduced ejection fraction. JACC Asia 3:315–316. https://doi.org/10.1016/j.jacasi.2022.11.013
Article PubMed Central PubMed Google Scholar
Greene SJ, Fonarow GC, Butler J (2020) Risk profiles in heart failure: baseline, residual, worsening, and advanced heart failure risk. Circ Heart Fail 13:e007132. https://doi.org/10.1161/CIRCHEARTFAILURE.120.007132
Greene SJ, Fonarow GC, Vaduganathan M et al (2015) The vulnerable phase after hospitalization for heart failure. Nat Rev Cardiol 12:220–229. https://doi.org/10.1038/nrcardio.2015.14
Butler J, Braunwald E, Gheorghiade M (2014) Recognizing worsening chronic heart failure as an entity and an end point in clinical trials. JAMA 312:789. https://doi.org/10.1001/jama.2014.6643
Article CAS PubMed Google Scholar
Metra M, Tomasoni D, Adamo M, et al (2023) Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the heart failure association of the European society of cardiology. Eur J Heart Fail. https://doi.org/10.1002/ejhf.2874
Heidenreich PA, Bozkurt B, Aguilar D, et al (2022) 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of cardiology/American heart association joint committee on clinical practice guidelines. Circulation 145. https://doi.org/10.1161/CIR.0000000000001063
Shakoor A, Emans ME, van Gent MWF et al (2023) Regional management of worsening heart failure: rationale and design of the CHAIN-HF registry. ESC Hear Fail. https://doi.org/10.1002/ehf2.14354
Greene SJ, Mentz RJ, Felker GM (2018) Outpatient worsening heart failure as a target for therapy. JAMA Cardiol 3:252. https://doi.org/10.1001/jamacardio.2017.5250
Article PubMed Central PubMed Google Scholar
Greene SJ, Bauersachs J, Brugts JJ et al (2023) Worsening heart failure: nomenclature, epidemiology, and future directions. J Am Coll Cardiol 81:413–424. https://doi.org/10.1016/j.jacc.2022.11.023
Greene SJ, Bauersachs J, Brugts JJ et al (2023) Management of worsening heart failure with reduced ejection fraction. J Am Coll Cardiol 82:559–571. https://doi.org/10.1016/j.jacc.2023.04.057
Kobayashi M, Voors AA, Girerd N et al (2020) Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF. Eur J Intern Med 71:62–69. https://doi.org/10.1016/j.ejim.2019.10.017
Pagnesi M, Adamo M, Sama IE et al (2021) Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF. Eur J Heart Fail 23:1750–1758. https://doi.org/10.1002/ejhf.2276
Article CAS PubMed Google Scholar
Tromp J, Beusekamp JC, Ouwerkerk W et al (2022) Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry. Eur J Heart Fail 24:645–652. https://doi.org/10.1002/ejhf.2431
Comments (0)